Wealth Enhancement Advisory Services
LUCD icon

Wealth Enhancement Advisory Services’s Lucid Diagnostics LUCD Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-26,393
Closed -$26.4K – 4346
2026
Q2 		$26.4K Buy
+26,393
New +$28.4K ﹤0.01% 4006

Other funds holding LUCD

Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Traphagen Investment Advisors
Traphagen Investment Advisors Oradell, New Jersey $1.46B AUM 14.92% 1-Year Est. Return
Sax Wealth Advisors
Sax Wealth Advisors Parsippany, New Jersey $3.5B AUM 13.73% 1-Year Est. Return
Anchyra Partners
Anchyra Partners Atlanta, Georgia $477M AUM 34.33% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Fortitude Family Office
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
True Wealth Design
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Essential Partners
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Wealth Enhancement Advisory Services's LUCD Position: Q3 2026 in Review

Wealth Enhancement Advisory Services sold out of Lucid Diagnostics (LUCD) in Q3 2026, closing a stake of 26,393 shares — an estimated $26.4K sold.

Wealth Enhancement Advisory Services first reported a position in LUCD in Q2 2026 and held it in 1 quarter. The position peaked at $26.4K in Q2 2026. 10 funds tracked by Wall St. Rank hold LUCD as of Q3 2026.

  • Wealth Enhancement Advisory Services reported no remaining Lucid Diagnostics position as of Q3 2026 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 26,393 Lucid Diagnostics shares in Q3 2026, an estimated $26.4K.
  • Wealth Enhancement Advisory Services first reported a position in Lucid Diagnostics in Q2 2026 and held it in 1 quarter.
  • Wealth Enhancement Advisory Services's Lucid Diagnostics position peaked at $26.4K in Q2 2026.
  • 10 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.